Prognostic factors for early recurrence after resection of pancreatic cancer: a systematic review and meta-analysis

CS Leonhardt, C Gustorff, U Klaiber, S Le Blanc… - Gastroenterology, 2024 - Elsevier
Background and aims Over half of pancreatic ductal adenocarcinomas (PDAC) recur within
12 months after curative-intent resection. The aim of this systematic review and meta …

Pancreas 2000. My journey with the central organ

JM Löhr - Pancreatology, 2024 - Elsevier
Abstract The European Pancreatic Club Lifetime Achievement Award is a distinction
awarded for research on the pancreas and service to European Pancreatology. It comes …

[HTML][HTML] Current considerations on intraductal papillary neoplasms of the bile duct and pancreatic duct

ET Pavlidis, IN Galanis, TE Pavlidis - World Journal of …, 2024 - ncbi.nlm.nih.gov
Pancreatobiliary intraductal papillary neoplasms (IPNs) represent precursors of pancreatic
cancer or bile duct cholangiocarcinoma that can be detected and treated. Despite advances …

Oncological Outcomes and Patterns of Recurrence after the Surgical Resection of an Invasive Intraductal Papillary Mucinous Neoplasm versus Primary Pancreatic …

TSA Abdalla, J Duhn, M Klinkhammer-Schalke… - Cancers, 2024 - mdpi.com
Simple Summary This retrospective study, based on data from the German Cancer Registry
Group of the Society of German Tumor Centers, analyzed a specific type of malignant cystic …

Is multidisciplinary treatment effective for invasive intraductal papillary mucinous carcinoma?

S Hirono, R Higuchi, G Honda, S Nara… - Annals of …, 2024 - Wiley Online Library
Background Surgical resection is standard treatment for invasive intraductal papillary
mucinous carcinoma (IPMC); however, impact of multidisciplinary treatment on survival …

Comparing survival after resection of pancreatic cancer with and without pancreatic cysts: nationwide registry-based study

M Gorris, NCM van Huijgevoort, A Farina, LAA Brosens… - Cancers, 2022 - mdpi.com
Simple Summary Pancreatic cancer has a poor prognosis, even in patients that can be
surgically treated with curative intent. An interesting subgroup of resected pancreatic …

[HTML][HTML] Pre-emptive resection for intraductal papillary mucinous neoplasia–Long-term outcome is similar between non-invasive and early invasive lesions in a tertiary …

Y Djoumi, O Sadr-Azodi, M Vujasinovic, M Del Chiaro… - Pancreatology, 2023 - Elsevier
Background Pre-emptive resection for intraductal papillary mucinous neoplasm (IPMN) aims
to reduce the risk before invasive transformation has taken place. Pancreatic resections are …

Pancreatic Cystic Neoplasms: Treatment, Surveillance and Prognosis

Y Vaalavuo - 2023 - trepo.tuni.fi
Background. Incidence of pancreatic cysts is rising. The main reasons for this increase are
ageing population, better imaging modalities and an increase in the use of imaging tests …

[HTML][HTML] Modern aspects of the management of pancreatic intraductal papillary mucinous neoplasms: a narrative review

ET Pavlidis, KG Sapalidis… - Romanian Journal of …, 2022 - ncbi.nlm.nih.gov
Intraductal papillary mucinous neoplasms (IPMNs) account for approximately 35% of all
cystic tumors in the pancreas and represent the largest subgroup. They are characterized by …

The impact of lymph node involvement on adjuvant chemotherapy and survival in patients with resected invasive intraductal papillary mucinous neoplasm: a …

W Gan, N Pu, J Han, H Yin, Q Chen, L Zhang… - Journal of … - journals.lww.com
Background: Limited knowledge and guidelines exist for invasive intraductal papillary
mucinous neoplasm (IPMN). This study aims to explore the significance of lymph node …